Meclocycline Sulfosalicylate Salt
Modify Date: 2024-01-02 16:36:06
Meclocycline Sulfosalicylate Salt structure
|
Common Name | Meclocycline Sulfosalicylate Salt | ||
|---|---|---|---|---|
| CAS Number | 73816-42-9 | Molecular Weight | 695.04800 | |
| Density | N/A | Boiling Point | 716.4ºC at 760 mmHg | |
| Molecular Formula | C29H27ClN2O14S | Melting Point | N/A | |
| MSDS | USA | Flash Point | 387.1ºC | |
Use of Meclocycline Sulfosalicylate SaltMeclocycline Sulfosalicylate Salt is a tetracycline antibiotic with broad-spectrum antibacterial activities, preventing skin bacterial infections such as acne vulgaris[1]. |
| Name | (4S,4aR,5S,5aR,12aR)-7-chloro-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide,2-hydroxy-5-sulfobenzoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Meclocycline Sulfosalicylate Salt is a tetracycline antibiotic with broad-spectrum antibacterial activities, preventing skin bacterial infections such as acne vulgaris[1]. |
|---|---|
| Related Catalog | |
| Target |
Bacterial[1] |
| References |
| Boiling Point | 716.4ºC at 760 mmHg |
|---|---|
| Molecular Formula | C29H27ClN2O14S |
| Molecular Weight | 695.04800 |
| Flash Point | 387.1ºC |
| Exact Mass | 694.08700 |
| PSA | 301.90000 |
| LogP | 2.33370 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi |
| RIDADR | NONH for all modes of transport |
|
Topical antibiotics in dermatology.
Arch. Dermatol. 124 , 1691-1700, (1988) Topical antibiotics are safe and effective in certain conditions, primarily acne, rosacea, and nasal carriage of Staphylococcus aureus. They are useful in impetigo only when it is of limited extent. T... |
|
|
The use of antibiotics in acne therapy: oral or topical administration?
J. Antimicrob. Chemother. 10 , 89-115, (1982)
|
|
|
Topical v systemic agent treatment for papulopustular acne. A cost-effectiveness analysis.
Arch. Dermatol. 120 , 1571-1578, (1984) We used cost-effectiveness analysis to compare the costs, risks, and benefits of two strategies for clearing papulopustular acne; topical therapy alone as initial therapy or a combination of systemic ... |
| 1,3,2-Dioxaborolane,2-(3-chloro-5-methylphenyl)-4,4,5,5-tetramethyl |
| MeClC6H3CH2B(pin) |
| 3-chloro-5-methylphenylpinacolborane |
| Meclocycline 2-hydroxy-5-sulfobenzoic acid |
| MeClC6H3B(pinacolato) |
| meclocycline 5-sulfosalicylate |
| 1-chloro-3-methylphenyl-5-BPin |
| meclocycline sulfosalicylate |